Ligand profile
ZINC5022931
Virtual-screening candidate from ZINC.
Bound to: VK055_3138 — 3-octaprenyl-4-hydroxybenzoate decarboxylase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC5022931- UniProt (similar protein)
A2QHE5- Tanimoto
- 0.645
- Target protein
- VK055_3138
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 83.6
- −1 ≤ LogP ≤ 5 2.57
- MW ≤ 500 Da 300.3
- LogP ≤ 5 2.57
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 83.6
Matches PAINS filter: hzone_phenol_B(215). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1cc(/C=N\N=C\c2ccc(O)c(OC)c2)ccc1OCOc1cc(/C=N\N=C\c2ccc(O)c(OC)c2)ccc1O
InChI=1S/C16H16N2O4/c1-21-15-7-11(3-5-13(15)19)9-17-18-10-12-4-6-14(20)16(8-12)22-2/h3-10,19-20H,1-2H3/b17-9-,18-10+InChI=1S/C16H16N2O4/c1-21-15-7-11(3-5-13(15)19)9-17-18-10-12-4-6-14(20)16(8-12)22-2/h3-10,19-20H,1-2H3/b17-9-,18-10+
GGQDJSIYHIRXDW-BUOZRGFLSA-NGGQDJSIYHIRXDW-BUOZRGFLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 4M4
- Homolog
- A2QHE5
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC5022931 →
- ZINC ZINC20 ZINC5022931 →
- UniProt UniProt A2QHE5 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC5022931”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3138.
PDB 22
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).